download pdf
Newest Medical Devices Presented to Venture Capitalists and Industry Leaders at MassMEDIC Event

Portable CT Scanner, Blood Type Converter, and Dissolvable Insulin Gel Among Technologies Featured; Secretary Daniel O’Connell Delivers Keynote at 9th Annual MedTech Investors Conference 

Boston, Mass. (November 1, 2007) – The Massachusetts medical device sector demonstrated its continued strength and ingenuity today at the 9th Annual MassMEDIC MedTech Investors Conference in Boston as 23 start-up, pre-venture companies presented their cutting-edge medical technologies before an audience of venture capitalists and industry leaders.

The companies showcased a range of new devices, including the first portable CT scanner; technology that converts all blood types to the universal “O” blood type; and numerous other innovative medical products.  Secretary of Housing and Economic Development, Daniel O’Connell, provided an update on the Governor’s recent life sciences initiative in his keynote speech.

Massachusetts is home to the nation’s second largest concentration of medical device manufacturing and development, with more than 225 manufacturers, 21,000 employees, annual shipments of $5.5 billion, and exports totaling $2.4 billion.

“The medical device sector in Massachusetts continues to be on the cutting edge of the industry nation- and world-wide,” said Tom Sommer, President of MassMEDIC. “The companies highlighted at this year’s conference are featuring numerous innovative technologies that have enormous potential to make significant contributions to healthcare globally, and to the economy locally,” he added.

As part of the daylong event, the group of 23 start-up firms made their pitches before venture capital firms and other potential investors. Some of the inventive technologies presented at the event included:

  • A non-invasive hemoglobin measurement device: that indicates anemia through an optical spectrometer, developed by Corum Medical of Framingham, Mass.
  • A device that enables surgical procedures on the surface of a beating heart: providing a superior alternative to closed-chest, beating heart procedures, developed by Heartlander Surgical ofWestwood,Mass.
  • A dissolvable insulin gel: used for treating patients with Type I and Type II diabetes, developed by SmartCells Inc. of Beverly, Mass.
  • A blood type conversion technology: that converts blood groups A, B, and AB into the universally transfusable group O, developed by ZymeQuest of Beverly, Mass.

The following companies and organizations presented their technology and business plans at the conference:

Abiomed(Danvers,MA)Coeurmetrics Inc. (Seabright,Nova Scotia)

Corum Medical (Framingham,MA)

Crescent Innovations (Worcester,MA)

DocuTemp (Bedford,MA)

Eleme Medical (Merrimack,NH)

Healagenics, Inc. (Woburn,MA)

Heartlander Surgical (Westwood,MA)

Highland Instruments (Cambridge,MA)

InfusSafe (Harvard,MA)

I-Therapeutix (Waltham,MA)

Rapid Micro Biosystems (Bedford,MA)

 

Sensors for Medicine, Inc. (Wayland, MA)Serica Technologies, Inc. (Medford,MA)

SIV Technologies, Inc. (Worcester,MA)

SmartCells, Inc. (Beverly,MA)

SmartSurfaces, Inc. (Somerville,MA)

Soundwave Research Laboratories, Inc. (Ashland,MA)

Speech Technology & Applied Research Corp. (Bedford,MA)

SteriCoat Corporation (Cambridge,MA)

Tepha, Inc. (Lexington,MA)

University of Massachusetts (Boston,MA)

ZymeQuest, Inc. (Beverly,MA)